Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Ponatinib is superior to imatinib in combination with chemotherapy for newly diagnosed Ph+ ALL

Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
Ponatinib is superior to imatinib in combination with chemotherapy for newly diagnosed Ph+ ALL ( Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA )
19 Dec 2023

SABCS 2023: Latest breast cancer diagnostics guidelines

Prof Nadia Harbeck and Prof Giuseppe Curigliano
SABCS 2023: Latest breast cancer diagnostics guidelines ( Prof Nadia Harbeck and Prof Giuseppe Curigliano )
13 Dec 2023

Cancer care in Needle Hospital, Hargeisa, Somaliland

Gebrekirstos Hagos - Needle Hospital, Hargeisa, Somaliland
Cancer care in Needle Hospital, Hargeisa, Somaliland ( Gebrekirstos Hagos - Needle Hospital, Hargeisa, Somaliland )
5 Dec 2023

Relapsed refractory multiple myeloma

Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India
Relapsed refractory multiple myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )
5 Dec 2023

The evolving paradigm in management of Multiple Myeloma

D Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India
The evolving paradigm in management of Multiple Myeloma ( D Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )
5 Dec 2023

First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/M cervical cancer

Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain
First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/M cervical cancer ( Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain )
4 Dec 2023

Trial investigates multiparametric prognostic score in early HR+/HER2- breast cancer

Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany
Trial investigates multiparametric prognostic score in early HR+/HER2- breast cancer ( Dr Oleg Gluz -  Krankenhaus Bethesda, Mönchengladbach, Germany )
21 Nov 2023

ESMO 2023: Highlights and analysis

Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2023: Highlights and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
8 Nov 2023

Cabozantinib shows clinically meaningful improvement in advanced neuroendocrine tumours

Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA
Cabozantinib shows clinically meaningful improvement in advanced neuroendocrine tumours ( Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA )
7 Nov 2023

Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer

Prof Ignace Vergote - UZ Leuven, Leuven, Belgium
Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer ( Prof Ignace Vergote - UZ Leuven, Leuven, Belgium )
7 Nov 2023

Lung Cancer

Dr Sabita Jiwnani - Tata Memorial Hospital, Mumbai, India
Lung Cancer ( Dr Sabita Jiwnani - Tata Memorial Hospital, Mumbai, India )
6 Nov 2023

2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvant pembrolizumab

Dr Sapna Patel - MD Anderson Cancer Center, Houston, USA
2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvant pembrolizumab ( Dr Sapna Patel -  MD Anderson Cancer Center, Houston, USA )
2 Nov 2023